What's new

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 4, Status: Authorised

Jun 25, 2025 - 16:30
 0
Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide,...

Next Article

New NATO commercial space strategy seeks to prompt more investment

Related Posts

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted),selvacovatein,damlecovatein, Date of authorisation: 30/03/2023, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 11, 2025  0

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers ...

May 19, 2025  0